Gilead Sciences Inc/ US3755581036 /
| 2024-11-14 3:46:01 PM | Chg. -0.5850 | Volume | Bid3:46:01 PM | Ask3:46:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 92.0450USD | -0.63% | 480,077 Turnover: 31.8 mill. |
92.0200Bid Size: 100 | 92.0700Ask Size: 400 | 114.97 bill.USD | 3.25% | 20.32 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 701.2000 | 774.4000 | 1,100.3000 | 1,166.2000 | 1,674 | ||||||
| Intangible Assets | 1,425.6000 | 2,067 | 11,736.4000 | 11,900.1000 | 11,073 | ||||||
| Long-Term Investments | 3,219.4000 | 63.7000 | 719.8000 | 439 | 1,598 | ||||||
| Fixed Assets | - | - | - | - | 16,950 | ||||||
| Inventories | 1,203.8000 | 1,390 | 1,745 | 2,055.8000 | 1,386 | ||||||
| Accounts Receivable | 1,622 | 1,951.2000 | 1,751.4000 | 2,100.3000 | 4,635 | ||||||
| Cash and Cash Equivalents | 907.9000 | 9,883.8000 | 1,803.7000 | 2,112.8000 | 10,027 | ||||||
| Current Assets | 5,708.1000 | 13,918.8000 | 6,156.3000 | 7,273.8000 | 17,714 | ||||||
| Total Assets | 11,592.6000 | 17,303.1000 | 21,239.8000 | 22,496.8000 | 34,664 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 803 | 1,206.1000 | 1,327.3000 | 1,255.9000 | 955 | ||||||
| Long-term debt | - | - | - | - | 11,921 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1.9000 | 40.6000 | 13.4000 | 94.2000 | 156 | ||||||
| Liabilities | 5,470.8000 | 10,435.8000 | 11,688.9000 | 10,752.3000 | 18,845 | ||||||
| Share Capital | .8000 | .8000 | .8000 | 1.5340 | 2 | ||||||
| Total Equity | 5,863.7000 | 6,738.9000 | 9,309.7000 | 11,369.1000 | 15,819 | ||||||
| Minority Interests | 258.1000 | 128.5000 | 241.1000 | 375.4000 | 393 | ||||||
| Total liabilities equity | 11,592.6000 | 17,303.1000 | 21,239.8000 | 22,496.8000 | 34,664 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,949.4000 | 8,385.4000 | 9,702.5000 | 11,201.7000 | 24,890 | ||||||
| Depreciation (total) | - | - | - | - | 125 | ||||||
| Operating Result | 3,962.2000 | 3,789.8000 | 4,010.2000 | 4,524 | 15,265 | ||||||
| Interest Income | -48.7000 | -138.8000 | -360.9000 | -306.9000 | -412 | ||||||
| Income Before Taxes | 3,913.5000 | 3,651 | 3,612 | 4,208.2000 | 14,856 | ||||||
| Income Taxes | 1,023.8000 | 861.9000 | 1,038.4000 | 1,150.9000 | 2,797 | ||||||
| Minority Interests Profit | 11.5000 | 14.6000 | 18 | 17.5000 | 42 | ||||||
| Net Income | 2,901.3000 | 2,803.6000 | 2,591.6000 | 3,074.8000 | 12,101 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,833.9000 | 3,639 | 3,194.7000 | 3,105 | 12,818 | ||||||
| Cash Flow from Investing Activities | -1,937.8000 | 3,589.8000 | -11,846.1000 | -254.4000 | -1,823 | ||||||
| Cash Flow from Financing | -1,338.7000 | 1,763.6000 | 563.3000 | -2,543.9000 | -3,025 | ||||||
| Decrease / Increase in Cash | -365.1000 | 8,975.9000 | -8,080.1000 | 309.1000 | 7,914 | ||||||
| Employees | 4,000 | 4,500 | 5,000 | 6,100 | 7,000 | ||||||
